SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Align Technology, Inc. (ALGN) and Abiomed, Inc. (ABMD) and Investigation of Peregrine Pharmaceuticals, Inc. (PPHM)

NEW YORK, Dec. 5, 2012 /PRNewswire/ --

Blyth, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the District of Connecticut on behalf of investors who purchased Blyth, Inc. (NYSE: BTH) stock between March 14, 2012 and November 6, 2012.

For more information, click here: http://zlk.9nl.com/blyth-bth.  You have until January 12, 2013 to request that the Court appoint you as lead plaintiff.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Align Technology, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who acquired Align Technology, Inc. (NasdaqGS: ALGN) securities between April 23, 2012 and October 17, 2012.

For more information, click here: http://zlk.9nl.com/align-technology-algn/. You have until January 28, 2013 to request that the Court appoint you as lead plaintiff.

Abiomed, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Abiomed, Inc. (Nasdaq: ABMD) stock between August 5, 2011 and October 31, 2012.

For more information, click here: http://zlk.9nl.com/abiomed-abmd.  

Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky is investigating potential claims on behalf of purchasers of Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities concerning possible breaches of fiduciary duty in connection with the disclosure of the discovery of major discrepancies in the treatment group of its Bavituxmab Phase II Second-Line Non-Small Cell Lung Cancer Trial.

For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/.  

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 

SOURCE Levi & Korsinsky, LLP

RELATED LINKS
http://www.zlk.com